Holen Sie sich die Stockscreener-App
5.95
3.30%
0.19
Handel nachbörslich:
5.85
-0.10
-1.68%
Schlusskurs vom Vortag:
$5.76
Offen:
$5.72
24-Stunden-Volumen:
1.12M
Relative Volume:
5.21
Marktkapitalisierung:
$2.94M
Einnahmen:
$4.70M
Nettoeinkommen (Verlust:
$-4.99M
KGV:
-0.9268
EPS:
-6.42
Netto-Cashflow:
$-5.29M
1W Leistung:
+9.37%
1M Leistung:
-47.11%
6M Leistung:
-67.75%
1J Leistung:
-76.80%
1-Tages-Spanne:
$5.25
$6.28
1-Wochen-Bereich:
$4.76
$6.28
52-Wochen-Spanne:
$4.76
$108.00
Salarius Pharmaceuticals Inc Stock (SLRX) Company Profile
Firmenname
Salarius Pharmaceuticals Inc
Sektor
Branche
Telefon
346-772-0346
Adresse
2450 HOLCOMBE BLVD, HOUSTON
Vergleichen Sie SLRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SLRX
Salarius Pharmaceuticals Inc
|
5.95 | 2.94M | 4.70M | -4.99M | -5.29M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Salarius Pharmaceuticals Inc Stock (SLRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-04-27 | Eingeleitet | Ladenburg Thalmann | Buy |
Salarius Pharmaceuticals Inc Aktie (SLRX) Neueste Nachrichten
Pattern recognition hints at Salarius Pharmaceuticals Inc. upsidePrice Action & Fast Gaining Stock Reports - Newser
Salarius Pharmaceuticals Granted Nasdaq Compliance Extension - TipRanks
Using data filters to optimize entry into Salarius Pharmaceuticals Inc.Trade Exit Summary & Verified Short-Term Plans - Newser
What machine learning models say about Salarius Pharmaceuticals Inc.Quarterly Trade Review & AI Forecast for Swing Trade Picks - Newser
Custom watchlist performance reports with Salarius Pharmaceuticals Inc.Market Activity Recap & Proven Capital Preservation Tips - Newser
Identifying reversal signals in Salarius Pharmaceuticals Inc.Portfolio Growth Summary & Intraday High Probability Setup Alerts - Newser
What recovery options are there for Salarius Pharmaceuticals Inc.Portfolio Performance Report & Long-Term Capital Growth Strategies - Newser
Will Salarius Pharmaceuticals Inc. continue its uptrendJuly 2025 Selloffs & Technical Entry and Exit Alerts - Newser
Signal strength of Salarius Pharmaceuticals Inc. stock in tech scannersRisk Management & Free Community Consensus Stock Picks - Newser
Heatmap analysis for Salarius Pharmaceuticals Inc. and competitorsJuly 2025 Sector Moves & High Win Rate Trade Tips - Newser
Salarius Pharmaceuticals files prospectus for $2.6 million at-the-market offering By Investing.com - Investing.com South Africa
Sector ETF performance correlation with Salarius Pharmaceuticals Inc.July 2025 Summary & Technical Pattern Based Buy Signals - Newser
Is Salarius Pharmaceuticals Inc. stock reversal real or fakeJuly 2025 Action & Verified Entry Point Detection - Newser
Reversal indicators forming on Salarius Pharmaceuticals Inc. stockOptions Play & Daily Profit Focused Stock Screening - Newser
Salarius Pharmaceuticals files prospectus for $2.6 million at-the-market offering - Investing.com
Salarius Pharmaceuticals Files Prospectus for Stock Offering - TipRanks
What earnings revisions data tells us about Salarius Pharmaceuticals Inc2025 Institutional Moves & Safe Swing Trade Setup Alerts - Newser
Is it time to cut losses on Salarius Pharmaceuticals Inc.July 2025 Summary & Low Risk High Reward Ideas - Newser
Technical signs of recovery in Salarius Pharmaceuticals Inc.July 2025 Trade Ideas & Real-Time Market Sentiment Alerts - Newser
What earnings revisions data tells us about Salarius Pharmaceuticals Inc.2025 Earnings Impact & AI Enhanced Trading Signals - Newser
Salarius Pharmaceuticals Inc. Approaches Support With Recovery in Sight getLinesFromResByArray error: size == 0 - 더경남뉴스
What analysts say about Salarius Pharmaceuticals Inc. stock outlookWeekly Market Summary & Reliable Breakout Stock Forecasts - Newser
How Efficient Is Salarius Pharmaceuticals Inc. at Controlling Operating CostsJuly 2025 Movers & Comprehensive Market Scan Insights - Newser
Is Salarius Pharmaceuticals Inc. meeting your algorithmic filter criteriaOil Prices & Daily Momentum Trading Reports - Newser
Advanced analytics toolkit walkthrough for Salarius Pharmaceuticals Inc.July 2025 Highlights & Free Risk Controlled Daily Trade Plans - Newser
Should you avoid Salarius Pharmaceuticals Inc. stock right nowCPI Data & Safe Swing Trade Setup Alerts - theviewers.co.kr
Will Salarius Pharmaceuticals Inc. outperform during market rallies2025 Dividend Review & AI Enhanced Trading Signals - theviewers.co.kr
Will Salarius Pharmaceuticals Inc. benefit from government policyQuarterly Trade Summary & Expert Curated Trade Setup Alerts - theviewers.co.kr
Can Salarius Pharmaceuticals Inc. continue delivering strong returns2025 Market WrapUp & Weekly Consistent Profit Watchlists - theviewers.co.kr
Market reaction to Salarius Pharmaceuticals Inc.’s recent newsJuly 2025 Intraday Action & Daily Stock Trend Reports - Newser
Will Salarius Pharmaceuticals Inc. outperform small cap indexesWeekly Trend Report & Detailed Earnings Play Strategies - theviewers.co.kr
Is a relief rally coming for Salarius Pharmaceuticals Inc. holdersCPI Data & Weekly Breakout Watchlists - Newser
Big Money Moves: Is Salarius Pharmaceuticals Inc. currently under institutional pressure2025 Analyst Calls & Long-Term Investment Growth Plans - theviewers.co.kr
Identifying reversal signals in Salarius Pharmaceuticals IncJuly 2025 Closing Moves & Scalable Portfolio Growth Ideas - Newser
Published on: 2025-08-22 17:33:49 - Newser
Published on: 2025-08-22 15:26:13 - beatles.ru
Salarius Pharmaceuticals Inc.’s Price Action Aligns with Quant SignalsJuly 2025 Trends & Capital Efficient Trade Techniques - beatles.ru
Is Salarius Pharmaceuticals Inc. in Accumulation Phase Now2025 Valuation Update & Fast Entry Momentum Alerts - classian.co.kr
Competitive Positioning of Salarius Pharmaceuticals Inc.: Is It Leading or LaggingJuly 2025 Update & Community Supported Trade Ideas - Newser
Using RSI to spot recovery in Salarius Pharmaceuticals Inc.2025 Analyst Calls & Reliable Volume Spike Alerts - Newser
Finanzdaten der Salarius Pharmaceuticals Inc-Aktie (SLRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):